Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) effectively treat advanced non-small cell lung cancer with EGFR-mutation. However, most patients develop acquired resistance without effective therapy subsequent to EGFR-TKI failure. We evaluated the efficacy of subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Xiaojuan, Zhang, Ye, Wang, Jinghui, Nong, Jingying, Li, Xi, Yang, Xinjie, Lv, Jialin, Zhang, Hui, Qin, Na, Zhang, Quan, Yue, Wentao, Zhang, Shucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632918/
https://www.ncbi.nlm.nih.gov/pubmed/26557904
http://dx.doi.org/10.1111/1759-7714.12236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632918/
https://www.ncbi.nlm.nih.gov/pubmed/26557904
http://dx.doi.org/10.1111/1759-7714.12236

Ejemplares similares